Luba Lopatinskaya

Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial

Clarissa E. Vergunst, Daniëlle M. Gerlag, Luba Lopatinskaya et al. · Arthritis & Rheumatism · 2008 · 232 citations

Elevated osteopontin levels in active relapsing‐remitting multiple sclerosis

Mario H. J. Vogt, Luba Lopatinskaya, Monique Smits et al. · Annals of Neurology · 2003 · 121 citations

The development of clinical activity in relapsing–remitting MS is associated with a decrease of FasL mRNA and an increase of Fas mRNA in peripheral blood

Luba Lopatinskaya, Anette H.H. van Boxel-Dezaire, Frederik Barkhof et al. · Journal of Neuroimmunology · 2003 · 22 citations

Autoimmune Disease, Immunology, Neurological Progress +8

Mediators of apoptosis Fas and FasL predict disability progression in multiple sclerosis over a period of 10 years

Luba Lopatinskaya, Jack Zwemmer, Bernard M.J. Uitdehaag et al. · Multiple Sclerosis Journal · 2006 · 21 citations